Acronym |
Definition |
| MPS II | Mucopolysaccharoidosis type II |
| MPS III | Mucopolysaccharoidosis type III |
| MRTD | Maximum Recommended Therapeutic Dose |
| MS | Multiple sclerosis |
| MTC | Masters in Therapeutic Counselling |
| MTC | Medullary thyroid cancer |
| MTIG | Microbiome Therapeutics Innovation Group |
| MTR | Maryland Therapeutic Riding |
| MTSR | Molecular Therapeutics Shared Resource |
| MTTN | Manitoba Therapeutic Touch Network |
| MTTP | Molecular Therapeutics Training Program |
| NAS | Neonatal abstinence syndrome |
| NCTM | National Center for Therapeutics Manufacturing |
| NGGT | Next Generation Gene Therapeutics |
| NHIG | Normal Human Immunoglobulin |
| NIDDK | National Institute of Diabetes and Digestive Kidney diseases |
| NIV | Non Invasive Ventilation |
| NLS | Non Linear System |
| NMT | Neurosequential Model of Therapeutics |
| NSPT | Niclosamide Stearate Prodrug Therapeutic |
| NTAP | Neurofibromatosis Therapeutic Acceleration Program |
| NTEV | Non Therapeutic Elective Ventilation |
| NTID | Narrow Therapeutic Index Drugs |
| NTRC | Naples Therapeutic Riding Center |
| NTRC | Northland Therapeutic Riding Center |
© Abbreviations.com